Medesis Pharma Sa Stock Fundamentals
| ALMDP Stock | EUR 0.35 0.03 7.89% |
Medesis Pharma SA fundamentals help investors to digest information that contributes to Medesis Pharma's financial success or failures. It also enables traders to predict the movement of Medesis Stock. The fundamental analysis module provides a way to measure Medesis Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medesis Pharma stock.
Medesis |
Medesis Pharma SA Company Price To Sales Analysis
Medesis Pharma's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Medesis Pharma Price To Sales | 189.31 X |
Most of Medesis Pharma's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medesis Pharma SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, Medesis Pharma SA has a Price To Sales of 189 times. This is much higher than that of the Healthcare sector and 92.37% higher than that of the Biotechnology industry. The price to sales for all France stocks is notably lower than that of the firm.
Medesis Pharma SA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medesis Pharma's current stock value. Our valuation model uses many indicators to compare Medesis Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medesis Pharma competition to find correlations between indicators driving Medesis Pharma's intrinsic value. More Info.Medesis Pharma SA is the top company in current valuation category among its peers. It also is number one stock in shares outstanding category among its peers creating about 0.51 of Shares Outstanding per Current Valuation. The ratio of Current Valuation to Shares Outstanding for Medesis Pharma SA is roughly 1.98 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medesis Pharma's earnings, one of the primary drivers of an investment's value.Medesis Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medesis Pharma's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medesis Pharma could also be used in its relative valuation, which is a method of valuing Medesis Pharma by comparing valuation metrics of similar companies.Medesis Pharma is currently under evaluation in price to sales category among its peers.
Medesis Fundamentals
| Current Valuation | 8.67 M | |||
| Shares Outstanding | 4.39 M | |||
| Shares Owned By Insiders | 17.28 % | |||
| Price To Book | 74.91 X | |||
| Price To Sales | 189.31 X | |||
| Revenue | 95.73 K | |||
| EBITDA | (3.05 M) | |||
| Net Income | (2.65 M) | |||
| Cash And Equivalents | 2.89 M | |||
| Total Debt | 1.28 M | |||
| Earnings Per Share | (0.74) X | |||
| Target Price | 4.1 | |||
| Market Capitalization | 13.43 M | |||
| Total Asset | 4.33 M | |||
| Z Score | 6.0 | |||
| Net Asset | 4.33 M |
About Medesis Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medesis Pharma SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medesis Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medesis Pharma SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Medesis Pharma SA, a clinical development stage biopharmaceutical company, engages in the development of orally administered molecule drug candidates to address unmet medical needs. The company was founded in 2003 and is based in Montpellier, France. MEDESIS PHARMA is traded on Paris Stock Exchange in France.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Medesis Stock Analysis
When running Medesis Pharma's price analysis, check to measure Medesis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medesis Pharma is operating at the current time. Most of Medesis Pharma's value examination focuses on studying past and present price action to predict the probability of Medesis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medesis Pharma's price. Additionally, you may evaluate how the addition of Medesis Pharma to your portfolios can decrease your overall portfolio volatility.